Calamos Wealth Management’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Other funds holding EW
Calamos Wealth Management's EW Position: Q3 2026 in Review
Calamos Wealth Management increased its Edwards Lifesciences (EW) stake by 6.1% in Q3 2026, buying an estimated $12.5K and bringing the position to 2,438 shares worth $210K. The position accounts for 0.01% of the portfolio, ranked #447.
Calamos Wealth Management first reported a position in EW in Q4 2016 and has held it in 27 quarters since. The position peaked at $7.37M in Q4 2021. 1,342 funds tracked by Wall St. Rank hold EW as of Q3 2026.
- Calamos Wealth Management held 2,438 shares of Edwards Lifesciences worth $210K as of Q3 2026.
- Calamos Wealth Management bought 141 Edwards Lifesciences shares in Q3 2026, an estimated $12.5K.
- Edwards Lifesciences made up 0.01% of Calamos Wealth Management's portfolio in Q3 2026, its #447 holding.
- Calamos Wealth Management first reported a position in Edwards Lifesciences in Q4 2016 and has held it in 27 quarters since.
- Calamos Wealth Management's Edwards Lifesciences position peaked at $7.37M in Q4 2021.
- 1,342 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2026.
Based on Calamos Wealth Management's 13F filing for Q3 2026, filed 2 Nov 2026.